ÂÜÀòÂÒÂ×

Tim is a Managing Partner of The Column Group. Since joining the firm in 2007, Tim has contributed to the conception, formation, and management of more than a dozen portfolio companies. Tim serves on the board of Carmot Therapeutics, Surrozen, Neurona Therapeutics, Nura Bio, Kallyope, Plexium, and Synthekine. He was previously the founding CEO at Peloton Therapeutics and also served as Chairman of the Board of Directors of Nurix Therapeutics.